1. Disodium Methanediphosphonate
2. Methane Diphosphonate
3. Methylene Diphosphonate
4. Methylene Diphosphonate, (32)p-labeled
5. Methylene Diphosphonate, Disodium Salt
6. Methylene Diphosphonate, Tetrasodium Salt
7. Methylene Diphosphonate, Tetrasodium Salt, (32)p-labeled
8. Methylene Diphosphonate, Tin(4+) Salt, (113)sn-labeled
9. Methylene Diphosphonate, Trisodium Salt
10. Methylene Diphosphonic Acid
1. 25681-89-4
2. Medronate Disodium [usan]
3. Disodium Methylene Diphosphonate
4. Disodium Medronate
5. Disodium Dihydrogen Methylenediphosphonate
6. Hay5mt18l3
7. Disodium Hydroxy-[[hydroxy(oxido)phosphoryl]methyl]phosphinate
8. Methylenebisphosphonic Acid-p,p'-disodium Salt
9. Phosphonic Acid, Methylenebis-, Disodium Dihydrogen Salt
10. Phosphonic Acid, P , P '-methylenebis-
11. Disodium;hydroxy-[[hydroxy(oxido)phosphoryl]methyl]phosphinate
12. Medronate Disodium (usan)
13. Sodium Methylenediphosphonate
14. Unii-hay5mt18l3
15. Disodium Methanediphosphonate
16. Schembl133343
17. Medronate Disodium [ii]
18. Chembl2105165
19. Dtxsid70948566
20. Medronate Disodium [vandf]
21. Medronate Disodium [mart.]
22. Medronate Disodium [who-dd]
23. Mfcd02258977
24. Akos017345141
25. D04886
26. Q27279835
27. Phosphonic Acid, P,p'-methylenebis-, Sodium Salt (1:2)
Molecular Weight | 219.97 g/mol |
---|---|
Molecular Formula | CH4Na2O6P2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 219.92785040 g/mol |
Monoisotopic Mass | 219.92785040 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 147 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 1 | |
---|---|
Drug Name | Cis-mdp |
PubMed Health | Technetium Tc 99m Medronate |
Drug Classes | Diagnostic Agent, Radiopharmaceutical Imaging |
Active Ingredient | Technetium tc-99m medronate |
Dosage Form | Injectable |
Route | Injection |
Strength | n/a |
Market Status | Prescription |
Company | Pharmalucence |
Bone Density Conservation Agents
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)
LOOKING FOR A SUPPLIER?